TY - JOUR
T1 - Influence of mortality on estimating the risk of kidney failure in people with stage 4 CKD
AU - Ravani, Pietro
AU - Fiocco, Marta
AU - Liu, Ping
AU - Quinn, Robert R.
AU - Hemmelgarn, Brenda
AU - James, Matthew
AU - Lam, Ngan
AU - Manns, Braden
AU - Oliver, Matthew J.
AU - Strippoli, Giovanni F.M.
AU - Tonelli, Marcello
N1 - Publisher Copyright:
Copyright © 2019 by the American Society of Nephrology.
PY - 2019
Y1 - 2019
N2 - Background Most kidney failure risk calculators are based on methods that censor for death. Because mortality is high in people with severe, nondialysis-dependent CKD, censoring for death may overestimate their risk of kidney failure. Methods Using 2002–2014 population-based laboratory and administrative data for adults with stage 4 CKD in Alberta, Canada, we analyzed the time to the earliest of kidney failure, death, or censoring, using methods that censor for death and methods that treat death as a competing event factoring in age, sex, diabetes, cardiovascular disease, eGFR, and albuminuria. Stage 4 CKD was defined as a sustained eGFR of 15–30 ml/min per 1.73 m2. Results Of the 30,801 participants (106,447 patient-years at risk; mean age 77 years), 18% developed kidney failure and 53% died. The observed risk of the combined end point of death or kidney failure was 64% at 5 years and 87% at 10 years. By comparison, standard risk calculators that censored for death estimated these risks to be 76% at 5 years and .100% at 7.5 years. Censoring for death increasingly overestimated the risk of kidney failure over time from 7% at 5 years to 19% at 10 years, especially in people at higher risk of death. For example, the overestimation of 5-year absolute risk ranged from 1% in a woman without diabetes, cardiovascular disease, or albuminuria and with an eGFR of 25 ml/min per 1.73 m2 (9% versus 8%), to 27% in a man with diabetes, cardiovascular disease, albuminuria .300 mg/d, and an eGFR of 20 ml/min per 1.73 m2 (78% versus 51%). Conclusions Kidney failure risk calculators should account for death as a competing risk to increase their accuracy and utility for patients and providers.
AB - Background Most kidney failure risk calculators are based on methods that censor for death. Because mortality is high in people with severe, nondialysis-dependent CKD, censoring for death may overestimate their risk of kidney failure. Methods Using 2002–2014 population-based laboratory and administrative data for adults with stage 4 CKD in Alberta, Canada, we analyzed the time to the earliest of kidney failure, death, or censoring, using methods that censor for death and methods that treat death as a competing event factoring in age, sex, diabetes, cardiovascular disease, eGFR, and albuminuria. Stage 4 CKD was defined as a sustained eGFR of 15–30 ml/min per 1.73 m2. Results Of the 30,801 participants (106,447 patient-years at risk; mean age 77 years), 18% developed kidney failure and 53% died. The observed risk of the combined end point of death or kidney failure was 64% at 5 years and 87% at 10 years. By comparison, standard risk calculators that censored for death estimated these risks to be 76% at 5 years and .100% at 7.5 years. Censoring for death increasingly overestimated the risk of kidney failure over time from 7% at 5 years to 19% at 10 years, especially in people at higher risk of death. For example, the overestimation of 5-year absolute risk ranged from 1% in a woman without diabetes, cardiovascular disease, or albuminuria and with an eGFR of 25 ml/min per 1.73 m2 (9% versus 8%), to 27% in a man with diabetes, cardiovascular disease, albuminuria .300 mg/d, and an eGFR of 20 ml/min per 1.73 m2 (78% versus 51%). Conclusions Kidney failure risk calculators should account for death as a competing risk to increase their accuracy and utility for patients and providers.
UR - http://www.scopus.com/inward/record.url?scp=85074378061&partnerID=8YFLogxK
U2 - 10.1681/ASN.2019060640
DO - 10.1681/ASN.2019060640
M3 - Article
C2 - 31540963
AN - SCOPUS:85074378061
SN - 1046-6673
VL - 30
SP - 2219
EP - 2227
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 11
ER -